American Association for Cancer Research

AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer

Bookmark and Share
AACR-IASLC Joint Lung Cancer Conference 2014


Third AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer
January 6-9, 2014
Hard Rock Hotel
San Diego, CA
Abstract submission deadline: Monday, November 4
Advance registration deadline: Tuesday, November 26

CONFERENCE CO-CHAIRPERSONS:
Elisabeth M. P. Brambilla, INSERM U823 - CHU Grenoble, Grenoble, France
Roy S. Herbst, Yale Cancer Center, New Haven, CT
Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA
William Pao, Vanderbilt University, Nashville, TN

PROGRAM COMMITTEE:
Denise R. Aberle, University of California, Los Angeles, CA
Bonnie J. Addario, Bonnie J. Addario Lung Cancer Foundation, San Carlos, CA
Myung-Ju Ahn, Sungkyunkwan University Samsung Medical Center, Seoul, South Korea
Robert C. Doebele, University of Colorado Denver, Aurora, CO
Peter S. Hammerman, Dana-Farber Cancer Institute, Boston, MA
David H. Harpole, Duke University Medical Center, Durham, NC
John V. Heymach, The University of Texas MD Anderson Cancer Center, Houston, TX
Tony S. K. Mok, Chinese University of Hong Kong, Hong Kong, China
Katerina A. Politi, Yale Cancer Center, New Haven, CT
Garth Powis, Sanford-Burnham Medical Research Institute, La Jolla, CA
Elda Railey, Research Advocacy Network, Plano, TX
Charles M. Rudin, Memorial Sloan-Kettering Cancer Center, New York, NY
Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, MA
Gabriella Sozzi, Istituto Nazionale dei Tumori, Milan, Italy
Avrum E. Spira, Boston University School of Medicine, Boston, MA
William C. Timmer, National Cancer Institute, Bethesda, MD
Ming-Sound Tsao, University of Toronto University Health Network, Toronto, ON, Canada
Seiji Yano, Kanazawa University Cancer Research Institute, Kanazawa, Japan

Under the leadership of Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association for Cancer Research (AACR), and Paul A. Bunn Jr., M.D., executive director of the International Association for the Study of Lung Cancer (IASLC), this jointly organized third conference on the Molecular Origins of Lung Cancer: Biology to Therapy, continued the series after successful conferences in 2010 and 2012. The 2014 conference brought together a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational, and clinical research) and provided a venue to discuss recent advances and establish new collaborations. As in past conferences, sessions ranged in topics spanning prevention, early detection, cancer stem cells, genomics, epigenetics, novel therapeutics, clinical trials, and patient advocacy. This conference is not only a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the many individuals charged with the study and treatment of this disease.

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available